Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Distillery Therapeutics

Targeting a CGRP-RAMP1-nociceptor axis for endometriosis

BC Staff
December 16, 2024 8:49 PM UTC

Inhibiting the interaction between the neuropeptide CGRP, which is produced by pain sensory neurons known as nociceptors, and its coreceptor RAMP1 on macrophages, could help treat endometriosis by preventing impairment of efferocytosis by peritoneal macrophages, decreasing endometrial lesion growth and its associated pain.

CGRP and RAMP1 were highly expressed in endometrial lesions from endometriosis patients. ...

Get Unlimited Access
Continue reading with a free trial.
Start a Free TrialLog In
Or Purchase This Article

BCIQ Company Profiles

Harvard Medical School